Literature DB >> 9182756

Structure of a cholesterol-binding, thiol-activated cytolysin and a model of its membrane form.

J Rossjohn1, S C Feil, W J McKinstry, R K Tweten, M W Parker.   

Abstract

The mechanisms by which proteins gain entry into membranes is a fundamental problem in biology. Here, we present the first crystal structure of a thiol-activated cytolysin, perfringolysin O, a member of a large family of toxins that kill eukaryotic cells by punching holes in their membranes. The molecule adopts an unusually elongated shape rich in beta sheet. We have used electron microscopy data to construct a detailed model of the membrane channel form of the toxin. The structures reveal a novel mechanism for membrane insertion. Surprisingly, the toxin receptor, cholesterol, appears to play multiple roles: targeting, promotion of oligomerization, triggering a membrane insertion competent form, and stabilizing the membrane pore.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9182756     DOI: 10.1016/s0092-8674(00)80251-2

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  156 in total

1.  Differential interaction of equinatoxin II with model membranes in response to lipid composition.

Authors:  J M Caaveiro; I Echabe; I Gutiérrez-Aguirre; J L Nieva; J L Arrondo; J M González-Mañas
Journal:  Biophys J       Date:  2001-03       Impact factor: 4.033

2.  Dissociated linkage of cytokine-inducing activity and cytotoxicity to different domains of listeriolysin O from Listeria monocytogenes.

Authors:  Chikara Kohda; Ikuo Kawamura; Hisashi Baba; Takamasa Nomura; Yutaka Ito; Terumi Kimoto; Isao Watanabe; Masao Mitsuyama
Journal:  Infect Immun       Date:  2002-03       Impact factor: 3.441

3.  Structure-function studies of tryptophan mutants of equinatoxin II, a sea anemone pore-forming protein.

Authors:  P Malovrh; A Barlic; Z Podlesek; P MaCek; G Menestrina; G Anderluh
Journal:  Biochem J       Date:  2000-02-15       Impact factor: 3.857

4.  The solution structure and oligomerization behavior of two bacterial toxins: pneumolysin and perfringolysin O.

Authors:  Alexandra S Solovyova; Marcelo Nöllmann; Timothy J Mitchell; Olwyn Byron
Journal:  Biophys J       Date:  2004-07       Impact factor: 4.033

5.  Perforin activity at membranes leads to invaginations and vesicle formation.

Authors:  Tilen Praper; Andreas F-P Sonnen; Ales Kladnik; Alberto O Andrighetti; Gabriella Viero; Keith J Morris; Emanuela Volpi; Lorenzo Lunelli; Mauro Dalla Serra; Christopher J Froelich; Robert J C Gilbert; Gregor Anderluh
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-15       Impact factor: 11.205

6.  Differential sensitivity of types 1 and 2 cholecystokinin receptors to membrane cholesterol.

Authors:  Ross M Potter; Kaleeckal G Harikumar; S Vincent Wu; Laurence J Miller
Journal:  J Lipid Res       Date:  2011-10-21       Impact factor: 5.922

7.  Structure of complement C6 suggests a mechanism for initiation and unidirectional, sequential assembly of membrane attack complex (MAC).

Authors:  Alexander E Aleshin; Ingrid U Schraufstatter; Boguslaw Stec; Laurie A Bankston; Robert C Liddington; Richard G DiScipio
Journal:  J Biol Chem       Date:  2012-01-20       Impact factor: 5.157

8.  Monomer-monomer interactions propagate structural transitions necessary for pore formation by the cholesterol-dependent cytolysins.

Authors:  Eileen M Hotze; Elizabeth Wilson-Kubalek; Allison J Farrand; Lori Bentsen; Michael W Parker; Arthur E Johnson; Rodney K Tweten
Journal:  J Biol Chem       Date:  2012-05-29       Impact factor: 5.157

9.  Accessibility of cholesterol in endoplasmic reticulum membranes and activation of SREBP-2 switch abruptly at a common cholesterol threshold.

Authors:  Anna Sokolov; Arun Radhakrishnan
Journal:  J Biol Chem       Date:  2010-06-23       Impact factor: 5.157

Review 10.  Membrane assembly of the cholesterol-dependent cytolysin pore complex.

Authors:  Eileen M Hotze; Rodney K Tweten
Journal:  Biochim Biophys Acta       Date:  2011-07-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.